Clinical association of miR-155-5p with breast cancer and its relevance for treatment with PARP inhibitors

被引:0
作者
Pasculli, Barbara [1 ]
Barbano, Raffaela [1 ]
Fontana, Andrea [1 ]
Biagini, Tommaso [1 ]
Di Viesti, Maria Pia [1 ]
Rendina, Michelina [1 ]
Valori, Vanna Maria [1 ]
Morritti, Maria [1 ]
Bravaccini, Sara [2 ]
Ravaioli, Sara [2 ]
Maiello, Evaristo [1 ]
Graziano, Paolo [1 ]
Murgo, Roberto [1 ]
Copetti, Massimiliano [1 ]
Mazza, Tommaso [1 ]
Fazio, Vito Michele [1 ]
Esteller, Manel [3 ,4 ,5 ,6 ]
Parrella, Paola [1 ]
机构
[1] IRCCS Casa Sollievo Sofferenza, San Giovanni Rotondo, Italy
[2] Ist Sci Romagnolo Studio & Cura Tumori IRST IRCCS, Meldola, Italy
[3] Josep Carreras Leukaemia Res Inst IJC, Barcelona, Spain
[4] Ctr Invest Biomed Red Canc CIBERONC, Barcelona, Spain
[5] Inst Catalana Recerca & Estudis Avancats ICREA, Barcelona, Spain
[6] Univ Barcelona, Barcelona, Spain
关键词
D O I
10.1158/1538-7445.AM2020-1422
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
1422
引用
收藏
页数:2
相关论文
共 50 条
[41]   An Overview of PARP Inhibitors for the Treatment of Breast Cancer [J].
Laura Cortesi ;
Hope S. Rugo ;
Christian Jackisch .
Targeted Oncology, 2021, 16 :255-282
[42]   Role of miR-155-5p expression and its involvement in apoptosis-related factors in thyroid follicular carcinoma [J].
Geng, Xiang ;
Sun, Yang-Yang ;
Fu, Jin-Jin ;
Cao, Liang ;
Li, Yuan .
JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS, 2020, 45 (04) :660-665
[43]   Circ_0008532 promotes bladder cancer progression by regulation of the miR-155-5p/miR-330-5p/MTGR1 axis [J].
Liang Chen ;
Xiong Yang ;
Jun Zhao ;
Ming Xiong ;
Raya Almaraihah ;
Zhaohui Chen ;
Teng Hou .
Journal of Experimental & Clinical Cancer Research, 39
[44]   Circ_0008532 promotes bladder cancer progression by regulation of the miR-155-5p/miR-330-5p/MTGR1 axis [J].
Chen, Liang ;
Yang, Xiong ;
Zhao, Jun ;
Xiong, Ming ;
Almaraihah, Raya ;
Chen, Zhaohui ;
Hou, Teng .
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH, 2020, 39 (01)
[45]   The role of miR-155-5p in MSI2 induced metastasis of prolonged DEHP exposed triple-negative breast cancer cells [J].
Jadhao, Mahendra Gunvantrao ;
Chiu, Chien Chih .
CANCER RESEARCH, 2022, 82 (04)
[46]   Effects of miR-155-5p regulating SIRT1 on diabetic nephropathy in mice [J].
Lin, Zhimin ;
Yu, Jiangshui .
INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE, 2021, 14 (04) :1617-1627
[47]   Diagnostic value of VDBP and miR-155-5p in diabetic nephropathy and the correlation with urinary microalbumin [J].
Bai, Xu ;
Luo, Qun ;
Tan, Kuibi ;
Guo, Liming .
EXPERIMENTAL AND THERAPEUTIC MEDICINE, 2020, 20 (05)
[48]   Exosomal miR-155-5p drives ibrutinib resistance in B-cell lymphoma [J].
Park, Bon ;
Choi, Myung Eun ;
Ryu, Kyung Ju ;
Park, Chaehwa ;
Choi, Minki ;
Yoon, Sang Eun ;
Kim, Won Seog ;
Kim, Hyeon Ho ;
Hong, Jung Yong ;
Kim, Seok Jin .
EXPERIMENTAL CELL RESEARCH, 2024, 442 (02)
[49]   The miR-155-5p/FBXO11 axis inhibits the progression of gastric cancer via the mTOR pathway [J].
Yuan, Tao ;
Liu, Haiyan ;
Li, Fangfang ;
Meng, Qingyue ;
Wang, Yajuan ;
Yuan, Mei .
TRANSLATIONAL CANCER RESEARCH, 2025, 14 (02) :1375-1387
[50]   MiR-155-5p inhibits PDK1 and promotes autophagy via the mTOR pathway in cervical cancer [J].
Wang, Fang ;
Shan, Shu ;
Huo, Yan ;
Xie, Zipeng ;
Fang, Yehong ;
Qi, Zhiying ;
Chen, Fengzhen ;
Li, Yongmei ;
Sun, Bei .
INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY, 2018, 99 :91-99